TARA Jacqueline Zummo sells $96K worth of shares
Mar 29, 2025, 10:31 AM
0.00%
What does TARA do
Protara Therapeutics, based in New York, develops treatments for rare diseases and is conducting Phase II trials for its lead candidate, TARA-002, in non-muscle invasive bladder cancer and lymphatic malformations. The company also works on IV Choline Chloride for patients needing parenteral nutrition.
Jacqueline Zummo sold 21,224 shares of TARA on 26 March at $4.53 per share, worth a total of $96K. They now own 98,861 TARA shares, or a 18% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.